Saturday 17 October 2026 Export TCRX’s income statement to Excel — free account

TScan Therapeutics, Inc.

TScan Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.3 million, up 266.7% from fiscal 2024. In the quarter to June 2026, revenue fell 65.8%, EPS grew 17.9%, free cash flow grew 19.0% and total debt rose 1.50%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.23 0.01 −4.17%

Follow TCRX

Alert me

Market cap: $16.2M
P/E: 0.0×
Fwd P/E: −1.1×
Dividend yield: —
F-score: 2/9
Altman Z: −3.54
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	1	2	2	3
ROE Full definition →		(76.44%)	(71.28%)	(80.95%)	(95.80%)
ROA Full definition →		(46.73%)	(43.26%)	(46.50%)	(50.09%)
ROIC Full definition →		0.00%	(2,610.99%)	(5,295.51%)	(4,588.23%)
Return on Tangible Assets Full definition →		(84.75%)	(88.14%)	(102.80%)	(145.00%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.05)	(1.08)	(0.96)	(0.91)
Free Cash Flow Full definition →		(135.85)	(139.73)	(124.96)	(118.41)
Capital Expenditures Full definition →		(5.12)	(4.41)	(2.94)	(2.13)
Other line items
Cash ROIC Full definition →		(37.64%)	(45.36%)	(48.50%)	(58.63%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		1,465.81%	1,105.57%	1,163.16%	1,364.56%
Selling, General and Administrative Expense of Revenue Full definition →		399.20%	309.81%	345.58%	430.59%
Share Based Compensation of Revenue Full definition →		147.36%	113.38%	117.74%	138.39%
Interest Coverage Full definition →		(52.15)	(49.05)	(46.31)	(43.22)
Operating CF/Net income Full definition →		0.92	1.04	0.98	0.99
Depreciation/Fixed assets Full definition →		0.31	0.33	0.35	0.37
Capex/Depreciation Full definition →		(1.80)	(1.54)	(1.02)	(0.74)
Revenue per Share Full definition →		0.06	0.08	0.07	0.05
Operating CF per Share Full definition →		(1.01)	(1.04)	(0.94)	(0.89)
Capex per Share Full definition →		(0.04)	(0.03)	(0.02)	(0.02)
Capex to Sales Full definition →		0.61	0.43	0.32	0.30

Show all line items

Columns are period end dates

Stockrow Weekly